MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-08-0038838
Icri Life Sciences Private Limited - life sciences in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹2.64 Cr
▲ 213% YoY
Net loss · FY 2023
₹5.48 Lakh
Net margin -2.1%
EBITDA · FY 2023
-₹7.07 Lakh
EBITDA margin -2.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Icri Life Sciences Private Limited
Data last updated:
Icri Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 28 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U73200DL2021PTC384327. Its GSTIN is 07AAGCI2386G1ZH (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amrit Chopra and Shyamal Ray.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 305 3rd Floor Deenar, Bhawan 44, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2023, the company reported a revenue of ₹2.64 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹5.48 Lakh (net margin -2.1%) and EBITDA of -₹7.07 Lakh (EBITDA margin -2.7%).
The company is associated with 1 brand: ICRI. Court records list 9 cases involving the company, including 9 filed against it; 7 cases are pending.
Icri Life Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0038838). For more details, the company can be reached via its website icriindia.com.
Company details
CIN U73200DL2021PTC384327
Registration Number 384327
Incorporation Date 28 July 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
MSME Classification Micro
Udyam Registration UDYAM-DL-08-0038838
Recognitions & Rankings of Icri Life Sciences
Contact details
Icri Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its website is icriindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address305 3rd Floor Deenar, Bhawan 44, New Delhi, Delhi, India – 110019
- IndustryLife Sciences, Biotechnology
To see the full contact details of Icri Life Sciences Private Limited, buy the company report.
Comprehensive company report
Icri Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Icri Life Sciences operates one associated brand: ICRI. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Institute provides degree and diploma programs in clinical research and allied healthcare | icriindia.com |
Business activity
The main business activity of Icri Life Sciences is information and communication. In detail, this covers other information & communication service activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| J | Information and communication | J8 | Other information & communication service activities |
To see the full business activity and turnover split of Icri Life Sciences Private Limited, buy the company report.
Financials of Icri Life Sciences Private Limited
FY 2023 filings availableIcri Life Sciences Private Limited reported revenue of ₹2.64 Cr (up 213% YoY) for FY 2023.
Revenue · FY 2023
₹2.64 Cr ▲ 213%
Net loss · FY 2023
₹5.48 Lakh margin -2.1%
EBITDA · FY 2023
-₹7.07 Lakh margin -2.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 213%
EBITDA CAGR growth
1 year
▲ 65%
Revenue rose 213% in the latest year. EBITDA rose 65% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ₹2.64 Cr | |
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹7.07 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹5.48 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -2.7% | |
| Net Profit Margin | -2.1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Icri Life Sciences Private Limited, buy the company report.
Board of directors of Icri Life Sciences Private Limited
Icri Life Sciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amrit Chopra | Director | 16 Apr 2025 | 1 Years 6 Months | Current |
| Shyamal Ray | Additional Director | 12 Nov 2025 | 0 Years 11 Months | Current |
Auditor
Icri Life Sciences Private Limited is audited by KANWARJITBAWASINGH for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KANWARJITBAWASINGH | FY 2023 | 083015 |
Shareholding
The shareholding of Icri Life Sciences Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Icri Life Sciences Private Limited, buy the company report.
Legal cases
Icri Life Sciences Private Limited has 9 court cases on record: 9 filed against it. 7 cases are pending and 2 are disposed.
Total cases
9
Filed against the company
9
Pending
7
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 9 | 7 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Commercial suit | Filed against the company by Yd Advertising Services Pvt. Ltd. | Pending |
| District court, Gurugram, Haryana | Cheque dishonour complaint | Filed against the company by M/S Collegedunia Web Pvt Ltd | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (SUMMONS FOR JUDGT) | Filed against the company by Outlier Innovations Private Limited Through Sidharth Singh | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Commercial matter | Filed against the company by Outlier Innovations Private Limited Through Sidharth Singh | Pending |
| District court, Gurugram, Haryana | Commercial suit | Filed against the company by Korra Worldwide Advertising Pvt Ltd | Pending |
To see the full case history of Icri Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Icri Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Icri Life Sciences Private Limited has 1 active EPFO establishment as of Apr 02, 2024.
Active EPFO establishments
1
GST
Icri Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAGCI2386G1ZH | Delhi | Active | 01 Sep 2021 |
To see the full GST registrations and return filing status of Icri Life Sciences Private Limited, buy the company report.
Recent activity
Icri Life Sciences Private Limited has 6 board changes on record since 2021: 4 appointments and 2 cessations. The latest: Sanjana Nahar ceased to be Director on 12 Nov 2025.
Ceased
Sanjana Nahar ceased to be Director.
Appointed
Shyamal Ray was appointed as Additional Director.
Appointed
Amrit Chopra was appointed as Director.
Ceased
Aman Jalota ceased to be Director.
AGM
Icri Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Icri Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
Appointed
Aman Jalota was appointed as Director.
Appointed
Sanjana Nahar was appointed as Director.
Incorporation
28 Jul 2021
Icri Life Sciences Private Limited was registered on 28 Jul 2021 with Roc Delhi & aged 5 years 2 months as per MCA records.
Frequently asked questions
Icri Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 28 July 2021 (5+ years old) and is registered under CIN U73200DL2021PTC384327.
Icri Life Sciences has 2 current directors:
- Amrit Chopra - Director
- Shyamal Ray - Additional Director
The latest financial statements of Icri Life Sciences on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Icri Life Sciences is 07AAGCI2386G1ZH, registered in Delhi.
The CIN (Corporate Identification Number) of Icri Life Sciences is U73200DL2021PTC384327. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Icri Life Sciences has 9 court cases on record: 9 filed against it. 7 are pending.
Icri Life Sciences was incorporated on 28 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Sanjana Nahar ceased to be Director on 12 Nov 2025. Shyamal Ray was appointed as Additional Director on 12 Nov 2025. Amrit Chopra was appointed as Director on 16 Apr 2025. Icri Life Sciences has 6 board changes on record in total.
Yes, Icri Life Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0038838).
Icri Life Sciences can be reached through the website icriindia.com. Its registered office is in New Delhi, Delhi, India.